Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Taro Pharmaceuticals is recalling Fluorouracil Topical Cream 5% because out-of-specification results were found in retain samples.
Lloyd Inc. of Iowa is recalling 3.7 million Thyro-Tab tablets because they do not meet in-process specification requirements and involve cGMP deviations.
GlaxoSmithKline is recalling specific lots of Arranon (nelarabine) Injection because drug-related impurities may exceed specification limits.
Samantha Lynn, Inc. is recalling Reumofan Plus Tablets because they contain undeclared drug ingredients, making them unapproved drugs.
Ranbaxy Inc. is recalling certain lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Ranbaxy Inc. is recalling specific lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Ranbaxy Inc. is recalling certain lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Mylan LLC is recalling 15,181 bottles of Tacrolimus Capsules 0.5 mg nationwide because retained samples failed USP content uniformity requirements.
Boehringer Ingelheim is recalling 8,381 bottles of Pradaxa 75 mg capsules because defective containers may allow moisture to enter, potentially impairing product quality.
Procter & Gamble is recalling 17,532 bottles of Vicks NyQuil Cold & Flu because portions of the dosing directions and warnings are obscured.
GlaxoSmithKline is recalling specific lots of Advair HFA inhalers because they failed to meet particle size distribution specifications.
GlaxoSmithKline is recalling 18,676 units of Advair HFA inhalers because they failed to meet particle size distribution specifications.
Vintage Pharmaceuticals is recalling 14,445 bottles of hydrocodone and acetaminophen tablets because confirmed complaints found oversized pills with superpotent drug levels.
Ranbaxy Inc. is recalling 32,208 bottles of Atorvastatin Calcium 10 mg tablets because a 20 mg tablet was found inside a sealed 10 mg bottle.
Watson Laboratories is recalling specific lots of Hydrocodone Bitartrate and Acetaminophen tablets because they may be oversized and superpotent.
American Enterprises LLC is recalling 750 kgs of Limed Bone Gelatin due to possible C. difficile contamination in the raw material.
Church & Dwight is recalling Orajel Kids My Way! toothpaste because Laureth-9 was mistakenly substituted for PEG during manufacturing.
Dr. Reddy's is recalling Quetiapine Fumarate Tablets, 25mg, because they failed USP dissolution testing during stability studies.
Ameridose LLC is recalling all sterile products manufactured in Westborough, MA, due to a lack of assurance of sterility. The recall is nationwide and includes all lot codes within expiry.
New England Compounding Center is voluntarily recalling all non-sterile products due to Good Manufacturing Practice (GMP) deviations. The recall covers products distributed nationwide and in Japan.
New England Compounding Center is recalling all of its sterile products because the company cannot assure that the products are sterile.
Ameridose LLC is voluntarily recalling all non-sterile products nationwide due to Good Manufacturing Practice (GMP) deficiencies. The recall was initiated in October 2012.
Stat Rx USA is recalling 22 units of Tobramycin Ophthalmic Ointment because the labels incorrectly identify the product as an ointment instead of a solution.
Stat Rx USA is recalling 5 bottles of Venlafaxine ER 150mg because the label incorrectly identifies the dosage form as 'Tabs' instead of 'Capsules.'
ITW Dymon is recalling specific lots of Lemon Hand Sanitizing Wipes because they were manufactured with raw material containing unknown particles believed to be water and dirt.